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Abstract
Huntington ́s disease (HD) is a progressive, neurodegenerative disease with a
fatal outcome. Although the disease-causing gene (huntingtin) has been known
for over 20 years, the exact mechanisms leading to neuronal cell death are still
controversial. One potential mechanism contributing to the massive loss of
neurons observed in the brain of HD patients could be the unfolded protein
response (UPR) activated by accumulation of misfolded proteins in the
endoplasmic reticulum (ER). As an adaptive response to counter-balance
accumulation of un- or misfolded proteins, the UPR upregulates transcription of
chaperones, temporarily attenuates new translation, and activates protein
degradation via the proteasome. However, persistent ER stress and an
activated UPR can also cause apoptotic cell death. Although different studies
have indicated a role for the UPR in HD, the evidence remains inconclusive.
Here, we present extensive bioinformatic analyses that revealed UPR
activation in different experimental HD models based on transcriptomic data.
Accordingly, we have identified 53 genes, including RAB5A, HMGB1,
CTNNB1, DNM1, TUBB, TSG101, EEF2, DYNC1H1, SLC12A5, ATG5, AKT1,
CASP7 and SYVN1 that provide a potential link between UPR and HD. To
further elucidate the potential role of UPR as a disease-relevant process, we
examined its connection to apoptosis based on molecular interaction data, and
identified a set of 40 genes including ADD1, HSP90B1, IKBKB, IKBKG, RPS3A
and LMNB1, which seem to be at the crossroads between these two important
cellular processes. Remarkably, we also found strong correlation of UPR gene
expression with the length of the polyglutamine tract of Huntingtin, which is a
critical determinant of age of disease onset in human HD patients pointing to
the UPR as a promising target for therapeutic intervention. The study is
complemented by a newly developed web-portal called UPR-HD
(http://uprhd.sysbiolab.eu) that enables visualization and interactive analysis of
UPR-associated gene expression across various HD models.
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Introduction
Huntington’s disease (HD) is an autosomal-dominant neurodegen-
erative disorder. Its symptoms include loss of motor control, cogni-
tive decline, and behavioural abnormalities. In most cases, the onset 
of the disease occurs between the age of 35 and 50. The outcome 
is always fatal with a life expectancy following the disease onset of 
around 20 years.
The treatment of HD has remained symptomatic, as currently there 
is still no cure. The cause of HD is a mutation in a single gene called 
huntingtin (HTT). In HD patients, an expansion of the CAG repeat 
in exon 1 of huntingtin has been identified1. This mutation results 
in an extended stretch of polyglutamine close to the N-terminus 
of the Huntingtin protein (HTT), which is involved in multiple 
molecular functions2,3. Although the molecular cause has been 
known now for over 20 years, the exact mechanisms leading to 
the observed massive cell death of neurons in the caudate nucleus 
of HD patients still await full clarification. A variety of processes 
such as excitotoxicity4,5, protein aggregation6–9 and transcriptional 
dysregulation10 have been suggested to contribute to neurodegen-
eration in HD. More recently, several studies have indicated that the 
unfolded protein response (UPR) might be implicated in neurode-
generative diseases including HD11–13.
ER stress and UPR
The endoplasmic reticulum (ER) is a crucial organelle for the 
correct folding and modification of numerous proteins. Upon the 
accumulation of unfolded or misfolded protein in the ER, several 
transcriptional and translational mechanisms are triggered to ensure 
fidelity of protein folding14,15. This stress response is better known 
as the UPR. In particular, the UPR stress sensors inositol-requiring 
enyzme1 (IRE1), activating transcription factor 6 (ATF-6) and 
PKR-like ER kinase (PERK) are activated in mammalian cells 
when the ER exceeds its capacity for correct folding. As an adap-
tive response to counter-balance accumulation of un- or misfolded 
proteins, the UPR (i) upregulates transcription of chaperones, 
(ii) temporarily attenuates new translation, and (iii) activates protein 
degradation via the proteasome16. The main function of the UPR is 
re-establishing homeostasis by increasing the overall folding capac-
ity. Although the primary role of UPR is an adaptive one, persistent 
ER stress can mediate toxicity and eventually lead to apoptosis 
through activation of JNK, ASK1 and caspase-12. Figure 1 depicts 
the different mechanisms and outcomes of UPR activation.
UPR and HD
ER stress and UPR have been indicated for a variety of neurode-
generative disorders, where protein misfolding plays a significant 
role18–20. For HD, finding a direct connection appears to be an enigma 
at first glance, since HTT is commonly thought to be located in the 
cystosol or eventually in the nucleus21, but not within the ER lumen. 
Thus, its misfolding should not trigger UPR. However, several pro-
posals have been put forward to describe how mutant HTT (mHTT) 
can induce an ER stress response12. For instance, experimental evi-
dence from HD cell models suggests that cytosolic mHTT frag-
ments strongly impair ER-associated protein degradation (ERAD), 
since mHTT entraps ERAD proteins22. This impairs the proper 
            Amendments from Version 1
In the updated version of the article, we included the results of 
additional analyses of differentially regulated UPR genes that 
were defined using less stringent requirements. This led to the 
identification of enlarged set of 53 proteins that link UPR and HD. 
Moreover, we distinguished between direct and indirect interactors 
of HTT, and supply these in the Supplementary materials. We also 
carried out analyses of additional RNA-Seq data for CAG repeat 
length-dependent gene expression and report the results showing 
that UPR gene expression tend to be strongly correlated with CAG 
repeat length. Finally, we briefly describe the newly implemented 
web-tool (UPR-HD freely accessible at http://uprhd.sysbiolab.eu) 
for visualisation and inspection of UPR-related gene expression in 
HD models and patients.
See referee reports
REVISED
Figure  1.  Phases  of  UPR  activation  and  putative  triggering  of 
ER stress by mHTT. One explanation for how UPR sensors IRE1, 
PERK and ATF6 are activated is through detachment of chaperone 
BiP in the presence of excess un- or misfolded protein. This leads 
subsequently to the execution of a series of molecular processes 
with different effector functions17. As an adaptive response, the UPR 
up-regulates transcription of chaperones, temporarily attenuates new 
translation, and activates protein degradation via the proteasome. 
Persistent levels of ER stress, however, may trigger inflammatory 
pathways as an alarm signal in addition to caspase activation, 
leading ultimately to the induction of apoptosis. Mutant Huntingtin 
(mHTT) might provoke ER stress through interference with different 
processes such as vesicular transport or ER-associated degradation 
(ERAD) resulting in accumulation of (misfolded) protein in the ER.
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protein catabolism, causing a potential accumulation of misfolded 
proteins in the ER, effectively interfering with its correct function-
ing. Another alternative route towards ER stress in HD could be the 
perturbation of vesicular trafficking by mHTT resulting in a gen-
eral protein overload in the ER or the disturbance of ER calcium 
homeostasis leading to a decreased folding capacity12. Moreover, 
HTT may even be an integral part of the ER stress response, as a 
reversible association of HTT via its highly conserved N-terminal 
domain with the ER membrane was observed23. Under stress con-
ditions, HTT is released and translocates to the nucleus, where it 
might impact on gene expression. Nuclear export and the subse-
quent re-attachment of HTT to the ER then terminate this stress 
response. It was suggested that such a potential control mechanism 
is disturbed through the nuclear accumulation of mHTT resulting in 
a perturbed ER in HD24.
Although various lines of investigations have shown a potential role 
for UPR in the pathogenesis of HD, it remains difficult to assess its 
overall influence, given that the animal models and cell lines used 
in each individual study display great variability and distinct char-
acteristics. Furthermore, most studies addressing the connection 
between UPR and HD focus on a small set of genes and proteins25,26. 
As the UPR presents a potentially important process in HD progres-
sion and a novel therapeutic target, we aimed to complement these 
previous studies with systematic and comprehensive bioinformatic 
analyses. Accordingly, using a systems biology approach, we gath-
ered all available data and focused on detecting the activation of 
UPR during HD, and also on elucidating the potential connection 
between UPR and apoptosis in HD.
First, we assembled different sets of genes associated with the UPR 
and examined whether the included genes show differential expres-
sion in HD models or patients, when compared to controls. Next, 
we examined the promoter regions of upregulated UPR genes and 
detected significant enrichment of characteristic stress response 
elements. Additionally, we performed functional enrichment analy-
sis on differentially expressed genes and found major biological 
processes implicated in UPR to be significantly over-represented. 
Furthermore, we assembled the UPR interactome and identified 
common proteins involved with apoptotic processes and interact-
ing with HTT, since those could provide crucial links between 
apoptosis and HD.
Materials and methods
Derivation of gene sets for UPR, apoptosis and HD
Since the UPR is a complex process, it is challenging to define a 
unique set of associated genes. Accordingly, we compiled three 
alternative gene sets that are either directly or indirectly involved 
in UPR, gathered from distinct sources. The first termed, UPR- 
KEGG-GO (n=265), was derived from Gene Ontology27 (http:// 
geneontology.org/page/go-database) (RRID:nif-0000-20935) as well 
as Reactome (http://www.reactome.org/) (RRID:nif-0000-03390)28 
and KEGG Pathway database29 (http://www.genome.jp/kegg/
pathway.html) (RRID:nlx_31015) databases indicated in Table 1. 
The second, referred to as UPR-Interactions (n=281), was gener-
ated by assembling molecular interactions of UPR components 
ATF6, ATF4, DDIT3, EIFAK3, ERNI and XBP1 using UniHI30 
(http://www.unihi.org/) (RRID:nif-0000-03609) and HDNetDB 
databases (http://hdnetdb.sysbiolab.eu). The third gene set, 
labelled UPR-Literature (n=2048) was compiled from published 
experimental studies31–34 performed in yeast and human cells using 
high-throughput techniques such as yeast two-hybrid, microarrays 
and ribosome profiling coupled with next generation sequencing, as 
well as from text-mining of the GeneCards database35 (http://www.
genecards.org) (RRID:nif-0000-02879) (Table 1).
In order to examine the genes involved in the cross-talk between 
UPR and apoptosis, we derived a list of genes that are either 
directly or indirectly involved in apoptosis from several differ-
ent sources, namely the Gene Ontology database (GO:0006915; 
Apoptotic process; n=431), KEGG pathway (hsa04210; Apoptosis; 
n=88), Reactome pathway database (REACT_578.8; Apoptosis; 
n=148; http://www.reactome.org/) (RRID:nif-0000-03390) and 
literature reviews (n=85)36–40. All genes included were annotated 
to be involved in the induction of apoptosis, anti-apoptosis, regula-
tion of apoptosis or were caspases (including both activators and 
inhibitors).
For establishing putative links to HD, we additionally put together 
two other gene sets: 
(i) HD Therapeutic Targets (HDTT) comprising 1033 genes. 
This set includes genes which were annotated by the 
curators of the HD Research CrossRoads database as 
being associated with HD based on experimental evi-
dence, making them potential therapeutic targets. A 
detailed description of this gene set is provided elsewhere 
by Kalathur et al.41. The list of HDTT can be accessed at 
http://hdtt.sysbiolab.eu/.
(ii) HTT interactors (HTT-int) including 1015 genes whose 
proteins have been shown to interact, or to be physically 
associated with HTT based on a diverse range of experi-
ments. The large number of interactors can be explained 
through the inclusion of high-throughput affinity puri-
fication experiments, which frequently results in the 
addition of indirect interactions (e.g. within complexes). 
This set of interactors was obtained from the HDNetDB 
database (http://hdnetdb.sysbiolab.eu) and can be found 
in Supplementary data file 8. The annotation available 
in HDNetDB was used to distinguish direct and indirect 
interactions. In total, 234 proteins were registered as 
direct interactors.
Collection and processing of HD gene expression data
All HD gene expression data used for this study were downloaded 
from the Gene Expression Omnibus (GEO) database42 (http://www.
ncbi.nlm.nih.gov/geo/) (RRID:nif-0000-00142). These data include 
gene expression from human brain and blood samples, human 
iPSCs, mouse, rat and yeast HD models, as well as murine cell 
lines (Table 2). All expression data sets were pre-processed using 
RMA (Robust Multi-array Average) implemented in R (available 
at http://www.r-project.org/) (RRID:nif-0000-10474) and analysed 
using several Bioconductor packages43,44 (RRID:nif-0000-10445). 
To enable the comparison across organisms, we mapped genes 
from mouse, rat, worm and yeast to orthologous human genes 
using HGNC Comparison of Orthology Predictions (HCOP) search 
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Table 2. List of HD gene expression datasets used for the gene set 
enrichment analysis.
GEO ID Sample Organism Pubmed id
GSE3790 HD (CN) vs Control Human 16467349
GSE24250 HD vs Control (blood) Human 21969577
GSE37547 HD-iPSC vs corrected HD iPSC Human 22748967
GSE3621 R6/1-18w, 22w, 27w vs WT Mouse 17696994
GSE9803 R6/2-12w vs WT Mouse 17519223
GSE10202 CHL2-22m vs WT Mouse 17519223
GSE9330 Ctip2-KO vs WT Mouse 18199763
GSE18551 YAC128-12, 24m vs WT Mouse 20089533
GSE3583 HdhQ111 vs WT Mouse 17708681
GSE9760 mESC (CAG150)-d4, d6 vs WT Mouse NA
GSE12481 Neuronal-culture 82Q vs CT Rat 18815258
GSE18644 Htt103Q vs Htt25Q Yeast 21044956
Table 1. Data sources used to compile UPR gene sets.
Gene set Sub-classification Number of genes
Total number of 
unique genes
UPR-KEGG-GO 
Pathway 
265
KEGG:04141: Protein processing in ER 165
REACTOME: Unfolded protein response 79
Gene ontology 
GO:003043: ER-associated ubiquitin-dependent protein catabolic process 38
GO:0030968: endoplasmic reticulum unfolded protein response 89
GO:0034976: response to endoplasmic reticulum stress 142
UPR-interactions 
Interactions 
281
ATF4 92
ATF6 34
DDIT3 73
EIF2AK3 13
ERN1 37
XBP1 111
UPR-Literature 
Publications (High through-put experiments) 1675
2048
Study Species Method
Labunskyy VM et al.31 Yeast Ribosome profiling coupled with NGS 189
Travers KJ et al.32 Yeast DNA microarray 745
Jonikas MC et al.33 Yeast Synthetic genetic array methodology & High-throughput flow cytometry 1262
Christianson JC et al.34 Human Affinity purification, LC-MS/MS,  High-throughput Y2H 75
GeneCards
GeneCards: ER-Stress 275
GeneCards: Unfolded Protein Response 325
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tool (available online at http://www.genenames.org/cgi-bin/hcop), 
which is based on integrated data from HUGO Gene Nomenclature 
Committee (HGNC)45 (RRID:nif-0000-02955).
Additionally, we evaluated an unpublished expression dataset 
(available at http://chdifoundation.org/datasets) generated by the 
CHDI Foundation. It comprises RNA-Seq measurements of stria-
tum, cortex and liver tissue taken from 6 month old heterozygote 
mice with CAG lengths of 20, 80, 92, 111, 140, and 175. The avail-
ability of data for distinct repeat lengths enables the examination 
whether expression changes are dependent on the length of the HTT 
polyglutamine tract. Spearman correlation between CAG number 
and gene expression measured as fragments per kilobase of exon 
per million reads mapped (FPKM) was calculated for each gene. 
False discovery rates (fdr) for positive and negative correlation were 
estimated by comparing the observed correlation coefficients with 
the distribution of correlation coefficients obtained for permutated 
data. For the latter, the CAG numbers of samples were permutated 
independently and repeatedly for each gene and subsequently cor-
related with the FPKM. Results are only reported for striatum, as 
preliminary analyses indicated only weak correlation for cortex and 
liver. The significance of overrepresentation of UPR genes among 
significantly correlated genes (fdr < 0.01) was assessed using the 
Fisher’s exact test.
Identification of differential expression using Gene Set 
Enrichment Analysis (GSEA)
We performed gene set enrichment analysis (GSEA)46 (RRID:nif-
0000-30629) comparing HD-associated expression to wild type or 
control data to identify differentially expressed genes. As input, we 
used the above-mentioned UPR gene sets and HD gene expression 
data. UPR genes were identified as significant when the enrichment 
score (ES) corresponded to a fdr ≤ 0.05 in HD gene expression data 
sets. For further analysis, we used only the genes present in the ‘UPR 
core enrichment’ gene sets. Those genes belonged to the leading-
edge subsets and contributed the most to the enrichment scores, 
and are the most differentially expressed among the UPR genes. To 
visualize these results, we generated Venn diagrams using jvenn47, 
to display the common genes across alternative comparisons.
Identification of stress response elements in the promoter 
regions
In order to verify the presence of unfolded protein response element 
(UPRE) and ER stress response elements (ERSE I and II)48 in the 
upstream regions (-1000bp to +500bp) of UPR genes upregulated 
in HD, we downloaded all the human promoter regions, (n=23322) 
available in the eukaryotic promoter database (EDP; http://epd.
vital-it.ch)49 (RRID:nif-0000-02806). Next, we used Regulatory 
Sequence Analysis Tools (RSAT)50 to map these elements in the 
promoters and computed the enrichment of these stress elements in 
promoters of upregulated UPR genes compared to all the human pro-
moters using hypergeometric test (equivalent to Fisher’s exact test).
Functional enrichment analysis
To identify enriched biological processes in our gene sets, we 
used BiNGO51 (RRID:nlx_149196) for Cytoscape52 (http://apps.
cytoscape.org/apps/bingo) (RRID:nif-0000-30404); and GSEA46 
(RRID:nif-0000-30629) to evaluate if genes from curated Reactome 
pathways (obtained from the Molecular Signature Database 
(MsigDB)53) were statistically over-represented. The significance of 
each identified biological process or pathway was calculated using 
the hypergeometric test, adjusted for multiple testing and converted 
to fdrs using the Benjamini and Hochberg method54 implemented in 
BiNGO (RRID:nlx_149196) or in GSEA (RRID:nif-0000-30629), 
respectively. We considered only those processes and pathways 
with an fdr of ≤ 0.05 to be significantly enriched.
Development of a web-portal for interactive analysis of 
UPR-associated gene expression
To enable the visualization and interactive inspection of expression 
of UPR genes across the integrated experiments, we implemented 
the UPR-HD tool. It is database with a web-interface based on a 
modified and enhanced version of the GeneXplorer software55. 
UPR-HD enables the query of individual or multiple UPR genes, the 
visualization of the expression changes observed in the microarray 
experiments and their export in table format for further usage. 
A help page gives an overview of the web-tool’s functionalities. 
UPR-HD can be freely accessed at http://uprhd.sysbiolab.eu.
Results and discussion
Identification of common UPR genes across HD gene 
expression studies
To determine possible implications of the UPR in HD, we sought to 
assess its activation using a computational approach and the evalu-
ation of existing data. First, we catalogued genes that are involved 
in UPR from several different sources and divided them into three 
different categories: UPR-KEGG-GO, UPR-Interactions and 
UPR-Literature as described in Material and Methods section and 
detailed in Table 1 and Supplementary Figure 1.
Since changes in gene transcription are main effects of UPR activa-
tion and published microarray data are available for HD in humans 
as well as for HD models, we collected 12 different gene expres-
sion datasets generated for the study of HD: three datasets included 
expression from human blood and brain samples as well as human 
induced pluripotent stem cells (iPSCs); seven datasets were derived 
from HD mouse models and cell cultures; one from rat cells and 
one from yeast cells. If the expression dataset constituted time-
series, we split the dataset according to the time points to maintain 
the temporal aspect of the expression changes.
We reasoned that UPR activity should be reflected in the regula-
tion of UPR genes. By applying GSEA we tested whether UPR 
genes tend to be differentially expressed in HD samples or mod-
els compared to the corresponding controls. GSEA was employed, 
since it is able to detect modest but consistent tendencies in expres-
sion change within a pre-defined set of genes. This can be seen 
as a crucial advantage, as only small changes in gene expression 
are frequently observed in the study of neurodegenerative disease 
due heterogeneity of tissue samples and biological variability of the 
underlying processes.
Remarkably, we found both indications for significant upregulation 
as well as repression of UPR genes in the different comparisons. 
Notably, significant differential expression was generally consistent 
across the three alternative UPR gene sets (with the exception of 
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R6/1 mice at 27 weeks, where UPR-Literature genes tended to be 
downregulated while UPR-GO-KEGG genes displayed upregula-
tion) (Figure 2). This observation implies that the obtained findings 
tend to be independent of the particular definition of UPR genes 
chosen in this study.
For most murine in vivo HD models, a significant upregulation 
was detected. Interestingly, the activation pattern was dependent 
on the time point of expression measurement for the two mouse 
models (R6/1 and YAC128), for which time series data were avail-
able. In the case of R6/1 mice, expressing exon 1 of the human 
HTT gene with a 115 CAG repeat, the most significant activation of 
UPR genes occurs after 18 and 22 weeks, while genes included in 
UPR-Literature and UPR-Interactions sets tend to be downregu-
lated after 27 weeks. In contrast, for YAC128 mice containing the 
full length human HTT gene with 128 CAG repeats, upregulation 
of UPR genes is only observed at the later time point (24 months), 
whereas downregulation dominates after 12 months. This diver-
gence may be explained by the rapid development of an aggressive 
disease phenotype in R6/1 mice compared to YAC128 mice, which 
show a milder phenotype with slower progression (Figure 2).
Inspecting the three human expression datasets, only the iPSC HD 
model showed a highly significant activation for all three UPR 
gene sets, whereas no consistent differential expression of the three 
UPR gene sets could be detected in blood and brain samples of 
HD patients. For whole blood samples, this observation might not 
be surprising, since erythrocytes - constituting the main component 
of blood - lack of an ER. The absence of a clear pattern in HD 
brain expression might be due to the fact that expression data were 
obtained from the post-mortem samples and thus represent typi-
cally only the very late stage of the disease. Finally, no significant 
alterations of expression were found for the rat in vitro and the yeast 
HD model (Figure 2).
Strikingly, expression of UPR genes also tended to display a strong 
correlation with the length of the polyglutamine tract in mice. 
Altogether, the expression of 10.6% of genes was found to be sig-
nificantly positively correlated, while 7.8% were negatively cor-
related with the number of CAG. More specifically, we obtained 
p-values of 1.7∙10-5, 7.7∙10-6 and 2.2∙10-16 for the overrepresenta-
tion of correlated UPR-KEGG-GO, UPR-Interactions and UPR- 
Literature genes, and p-values of 0.10, 3.9∙10-5 and 4.6∙10-15 for the 
overrepresentation of anti-correlated genes, respectively.
Next, we sought to identify UPR genes which showed conserved 
differential regulation in distinct HD models. For this purpose, we 
collected genes that were assigned to the enrichment core by GSEA 
in the comparisons that showed significant upregulation of UPR 
genes. In total we collected the UPR genes contained in the enrich-
ment cores from six murine HD models (including one cell line) 
and the human HD iPSC model. Intersection of these sets led to the 
identification of 132 genes that were commonly upregulated, when 
UPR activation was indicated (Figure 3, Supplementary data file 1). 
We refer to this set of genes as UPR-HDup.
As the UPR has also been associated with suppression of gene tran-
scription and the enhanced degradation of numerous transcripts56,57, 
we carried out the equivalent procedure to identify UPR genes 
whose downregulation is conserved in different HD models. 
Here, we intersected the enrichments core from five comparisons 
displaying suppression of UPR genes (Supplementary Figure 2, 
Supplementary data file 2). This resulted in 81 commonly down-
regulated genes. We refer to the combined set of UPR genes (con-
sisting of 132 upregulated and 81 downregulated genes) that were 
commonly detected as differentially regulated in HD gene expres-
sion data as UPR-HDdiff.
To capture a larger number of dysregulated UPR genes, we generate 
alternative gene lists with less stringent requirement for inclusion. 
In particular, we derived 876 upregulated genes by requiring that 
they needed to be included in the enrichment cores of the human 
iPSC and only four out of six murine HD models (Supplementary 
data file 1). Similarly, a less stringent list was generated with 
388 genes showing downregulation in at least four comparisons 
(Supplementary data file 2).
Examining stress response elements in the promoter 
regions of upregulated UPR genes
To assess whether the observed upregulation indeed reflects the 
activation of UPR or if it might be a consequence of other unre-
lated processes, we carried out an analysis of the promoter regions 
of genes included in UPR-HDup. We searched for the presence of 
sequence elements that indicate binding of transcription factors 
associated with the UPR. In particular, we searched for unfolded pro-
tein response elements (UPRE; TGACGTG (G/A)) and the alterna-
tive ER stress response elements I (ERSE I; CCAAT(N9)CCACG) 
and II (ERSE II; ATTGG-N-CCACG) in promoter regions (-1000 bp 
to +500 bp) regions of UPR-HDup genes. These characteristic 
Figure 2. Differential  regulation of UPR gene sets detected  in HD expression data. For each of the compiled UPR genes sets, the 
normalized enrichment scores (NES) produced by GSEA are shown for different comparisons of HD-associated expression with controls. 
Positive scores indicate a tendency towards upregulation; negatives scores indicate a tendency towards downregulation of genes in the UPR 
sets. Comparisons that showed significant upregulation of UPR gene sets (fdr ≤ 0.05 and NES ≥ +1.4) are highlighted by red background, 
while significant downregulation (fdr ≤ 0.05 and NES ≤ +1.4) by green background.
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sequence elements are targeted by the bZIP transcription factors 
ATF6 and XBP1, which are main mediators of the transcriptional 
adaptation evoked by UPR58.
Strikingly, we found that the vast majority of the UPR-HDup has 
such a characteristic binding sequence in their promoter regions 
(Supplementary Figure 3). Compared to number of sequence ele-
ments that we would expect by chance, a highly significant overrep-
resentation was detected for the UPR-HDup genes. More specifically, 
we found the occurrence of UPRE in 104 genes (p=3.0∙10-9), ERSE-I 
in 93 genes (p=0.0019), and ERSE-II in 8 (p=0.052). Notably, a 
large number of UPR-HDup genes had alternative binding motifs 
included in the promoter region: 70 genes had both ERSE-I and 
UPRE, 2 genes had both ERSE-I and ERSE-II and six genes had 
all three elements (for list of genes see Supplementary data file 3) 
which might suggest that these genes are under particularly tight 
control of UPR-associated transcription factors ATF6 and XBP1. 
We also detected a highly significant enrichment for the less strin-
gent list of upregulated UPR genes. Here, we found that 684 genes 
have UPRE (p=4.4∙10-41), 562 have ERSE-I (p=4.4∙10-5) and 56 have 
ERSE-II (p=3.8∙10-5) in their promoter region (Supplementary data 
file 3). Altogether, the results of the promoter analysis support the 
conclusion that the upregulation of UPR genes in HD models 
faithfully reflects an activated UPR.
Biological processes that are enriched in differentially 
expressed UPR genes
Since the UPR comprises a complex series of diverse molecu-
lar mechanisms, we examined the functional composition of 
UPR-HDdiff genes. For this purpose, we performed functional analy-
sis using BiNGO to identify enriched biological processes (as defined 
in GO) that are overrepresented among UPR-HDdiff genes. All the 
biological processes that are significantly enriched in our analysis 
are listed in Supplementary data file 4 as well as those for the less 
stringent list of differentially regulated UPR genes. Expectedly, we 
detected that stress-related functional categories such as ‘response 
to stress’ (GO ID:6950; n=44; fdr=2.08E-03) and ‘response to 
unfolded protein’ (GO ID:6986; n=13; fdr=4.55E-09) were enriched 
(Figure 4a). A second group of significantly overrepresented 
GO categories were related to ‘protein transport’ (GO ID:15031; 
n=34; fdr=1.76E-07) and ‘protein localization’ (GO ID:8104; 
n=36; fdr=1.19E-06) including ‘vesicle-mediated transport’ 
(GO ID:16192; n=24; fdr=9.03E-05) and ‘ER to Golgi vesicle-
mediated transport’ (GO ID:6888; n=4; fdr=4.00E-02) (Figure 4b). 
Figure 3. Up regulated UPR genes. Genes included in the core enrichment set for comparisons that indicated UPR activation (highlighted 
in red in Figure 2) were compared. Common upregulated UPR genes (n=169) in six HD murine models (left side) were intersected with 
upregulated UPR genes in human HD iPSCs (right side) resulting in a set of 132 UPR genes, whose activation was conserved across the 
different HD models. The bar plots (bottom) display the number of UPR genes assigned to the core enrichment sets for comparisons that 
indicated upregulation.
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Additionally, we also found ‘ER-nucleus signalling pathway’ (GO 
ID:6984; n=9; adjp-value=1.81E-07) to be highly enriched. It has 
been previously reported that ER-nucleus signalling pathway func-
tions via activation of NF-κB due to ER-overload triggered by 
protein congestion59.
Furthermore, UPR-HDdiff genes tended to be associated with pro-
tein catabolism and in particular protein degradation (Figure 4c). 
Significant processes here were e.g. ‘protein catabolic process’ 
(GO ID:30163; n=18; fdr=6.40E-05), ‘proteasomal ubiquitin- 
dependent protein catabolic process’ (GO ID:43161; n=13; 
fdr=6.69E-06) and ‘protein ubiquitination’ (GO ID:31396; n=7; 
fdr=3.12E-02). These results coincide well with previous studies 
establishing the connection of UPR and ERAD and showing, for 
instance, that the extent of activation of the UPR is concurrent with 
the severity of ERAD defect60.
Finally, genes linked to apoptosis could be found among the 
UPR-HDdiff genes (Figure 4d). Of particular interest for potential 
intervention could be genes associated with ‘regulation of apop-
tosis’ (GO ID:42981; n=24; fdr=1.65E-02), as their manipulation 
may prevent the execution of the apoptotic programme under per-
sistent ER stress.
In summary, UPR genes detected as commonly differentially regu-
lated in HD expression data were not restricted to a particular func-
tional category, but can be associated with many processes linked 
to the UPR.
Pathways enriched in upregulated genes
Complementary to the functional composition, we evaluated 
whether specific pathways might be activated based on the 
observed commonly upregulated UPR genes (UPR-HDup). There-
fore, we carried out pathway enrichment analysis using a set of 
pathways curated in the Reactome database. As expected, ‘unfolded 
protein response’ (n=6; fdr=2.04E-05), ‘activation of genes by 
ATF4’ (n=3; fdr=0.00291) and ‘PERK regulated gene expression’ 
(n=3; fdr=0.0033) were detected as significantly enriched among 
UPR-HDup genes (Figure 5). More interestingly, we also found an 
overrepresentation of components of the ‘immune system’ (n=14; 
fdr=6.74E-05), ‘adaptive immune system’ (n=6; fdr=1.96E-03), 
‘NGF signalling’ (n=9; fdr=2.42E-03), and ‘Diabetes pathways’ 
(n=7; fdr=2.04E-05). Complete results from the analysis are 
included in Supplementary data file 5.
Remarkably, recent studies have also suggested that ER stress and 
activated UPR are interconnected with inflammatory processes61. 
Inflammation is an immunological process usually carried out 
by the vascular system to counteract disease, and to fight foreign 
antigens against invasion. Within the brain, microglia and astrocytes 
play important immunological functions. Until very recently, little 
was known about inflammatory molecules in HD. Recent studies, 
however revealed a distinct profile of inflammatory mediators from 
post-mortem human HD tissue62,63. Inflammatory mediators such as 
IL-1β and TNF-α were increased only in the striatum, whereas IL-6, 
IL-8 and MMP-9 were also upregulated in cortex and in the 
cerebellum63. This supports the conjecture that secreted inflammatory 
Figure 5. Pathways enriched among upregulated UPR genes. The network of pathways with overrepresentation of upregulated UPR genes 
are shown. Node size represents number of genes in each pathway and connecting line size represents number of genes shared between 
two pathways. Colour coding from white to red indicates increasing statistical significance. Pathways were derived from the Reactome 
database.
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cytokines and activated microglia cells could lead to axonal dam-
age and extensive neuronal cell death in HD pathology62–65. In gen-
eral, activated microglia exert their diverse effects on neurons and 
macroglia (astrocytes and oligodendrocytes). Inflammation occurs 
through the release of cytoprotective agents such as growth factors, 
plasminogen, and neuroprotective cytokine as well as cytotoxic sub-
stances such as oxygen radicals, nitricoxide, glutamate, proteases, 
and neurotoxic cytokines. One of the earliest reports describing 
microglial abnormalities in HD was provided by Singhrao et al.65. 
Microglial cell counts were considerably increased in the caudate 
putamen of HD and these microglial cells expressed increased 
amounts of complement factors. A more detailed investigation of 
microglial morphological changes associated with HD was per-
formed by Sapp et al.66. The authors localized morphologically acti-
vated microglial cells in the neostriatum, cortex and globus pallidus 
as well as in adjoining white matter of HD brains. Additionally, 
positron emission tomography (PET) studies using the ligand for 
benzodiazepine receptor (PK-11195), which labels activated micro-
glia have been employed to study of neuroinflammation. Using 
this technique, Tai et al.67,68 demonstrated that microglial activa-
tion in HD patients correlates with disease progression as assessed 
by loss of dopamine D2 receptor binding sites. Interestingly, Tai 
et al. could also demonstrate that microglial activation and release 
of cytokine IL-6 can be observed in presymptomatic HD gene carri-
ers and can be detected up to 15 years before predicted age of onset. 
These findings indicate the microglial inflammatory activation is an 
early event associated with subclinical progression of HD and may 
constitute a target for early therapeutic intervention.
Besides the indication of processes related to the immune response, 
results of the pathway enrichment analysis also pointed to diabe-
tes. It has been shown that diabetes in Wolcott-Rallison syndrome 
(a rare autosomal recessive form of juvenile diabetes) is a result of 
high levels of ER stress caused by mutations in the PERK gene in 
pancreatic β-cells. In addition, studies have shown that HD patients 
show increased incidence of diabetes69,70 and HD transgenic mice 
develop hyperglycemia71,72. More recently it has been experimen-
tally validated that HD transgenic mice develop intranuclear inclu-
sions in the pancreatic β-cells, causing an intrinsic defect in insulin 
production73.
For the enlarged list of upregulated UPR genes, additional pathways 
were detected to be significantly enriched (Supplementary data file 5). 
For instance, genes associated with cell cycle and apoptosis were 
strongly overrepresented among the upregulated UPR genes.
Prioritization of UPR-HD connectors through integrative 
analysis
To narrow down the list of UPR-HDdiff genes for further inspec-
tion, we utilized additional information, including a reference 
set of potential molecular targets for HD therapy that were made 
available through the HD Research Crossroads database initiated 
by the CHDI Foundation (see Kalathur et al. 2012)41. Genes were 
included by experts in the field based on the evaluation of pub-
lished literature and in-house screens using a set of defined criteria 
(see Kalathur et al. 2012)41. For instance, a gene was considered as 
a potential HDTT if genetic or pharmacologic modification of its 
activity led to a change of a HD-related phenotype in a validated 
cell culture or organism model of HD. At present, this curated refer-
ence set constitutes the most comprehensive collection of HDTTs. 
In addition, we extracted genes, whose corresponding proteins were 
reported to be physically associated with HTT, from the HDNetDB 
database. We recently demonstrated that HTT interactors tend to 
be enriched in proteins that influence the toxicity of mHTT, and 
provide favourable candidates for the identification of molecular 
modifiers of HD74.
We reasoned that differentially regulated UPR genes, which have 
been shown to influence HD-related phenotypes and to be physi-
cally associated with HTT, could constitute molecular links between 
UPR and HD. Therefore, we integrated the three gene lists and iden-
tified 13 genes that were common to all three: RAB5A, HMGB1, 
CTNNB1, DNM1, TCP1, TUBB, TSG101, DNAJB1, CCT2, EEF2, 
DYNC1H1, HSPA5 and SLC12A5 (Supplementary Figure 4). Most 
of the corresponding proteins are indirect interactors of HTT, while 
two (CTNNB1, DNM1) interact directly (Table 3, Supplemen-
tary Figure 4). Notably, the search for stress response elements in 
the upstream regions of these 13 genes revealed that eight genes 
(RAB5A, HMGB1, CTNNB1, DNM1, TCP1, TUBB, TSG101 and 
DNAJB1) possess either UPRE or ERSE or both elements in their 
promoters, suggesting that these genes are under direct control 
of UPR-associated transcription factors (Table 3). Moreover, the 
expression of the 13 gene tends to be strongly correlated with the 
length of the polyglutamine tract in HD mice. Indeed, 9 of the 
13 genes were found to be significantly correlated, whereas we 
would expect only 1.4 by chance.
Inspection of the genes possessing UPRE or ERSE elements in 
their promoter regions revealed that four of them (TCP1, CCT2, 
DNAJB1 and HMGB1) have been reported to act as chaperones. 
Besides being essential components of the UPR, molecular chaper-
ones can modulate the aggregation and toxicity of proteins, includ-
ing mHTT. TCP1 (CCT1) and CCT2 are components of the TCP1 
ring complex (TRiC) that uses cycles of ATP-binding and hydrolysis 
to bind unfolded polypeptides and facilitate their folding. Notably, 
TRiC has been identified as a potent suppressor of mHTT medi-
ated toxicity and inhibitor of the mHTT protein aggregation in vitro 
and in vivo75. DNAJB1 belongs to the group of DnaJ/Hsp40 (Heat 
shock protein 40) proteins that are involved in protein translation, 
folding and translocation through regulating ATPase activity of the 
Hsp70s chaperones. In a PC12 cell model, experiments indicated 
that DNAJB1 attaches to soluble mHTT oligomers and recruits 
Hsp70 suppressing mHTT mediated toxicity76. Finally, HMGB1 
encodes for the High-mobility group box 1 protein (HMGB1), 
which has recently been demonstrated to have chaperone-like activ-
ity, inhibiting aggregation of various proteins. Overexpression of 
HMGB1 can also decrease the aggregation induced by extended 
polyQ stretches77.
Intersecting the less stringent list of differentially regulated UPR 
genes with HTT interactors and HDTT led to the identification of 
additional 40 genes that might link UPR and HD (Supplementary 
dataset 9). Of particular interest might be 15 genes, whose cor-
responding proteins are direct interactors of HTT. They include 
ubiquilin 1 (UBQLN1), the ubiquitin ligase synoviolin (SYVN1) 
involved in ERAD and the ubiquitin ligase ATG5, which is 
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necessary for autophagy, as well as the initator (CASP2) and effec-
tor (CASP7) caspases. Moreover, the major molecular regulators 
such as TP53, AKT1 and SP1 are members of this candidate set.
Linking the UPR network to apoptosis and HTT
A crucial aspect of the UPR in the context of HD is the possibility 
that it can trigger apoptosis upon persistent ER stress. To obtain a 
comprehensive view of the connections between UPR and apopto-
sis, we applied a network approach. First, we generated the UPR 
interactome from known protein interactions of UPR core compo-
nents, which we extracted from the UniHI and HDNetDB databases 
(Supplementary data file 6). Second, we compiled a list of genes 
(n=594) associated with apoptosis from several different sources 
(as described in the materials and methods). We then used this list to 
identify 40 proteins associated with apoptosis within the UPR inter-
actome (Supplementary data file 7). These genes included, among 
others, Apoptosis Signal Regulating Kinase 1 (ASK1, also known 
as MAP3K5), whose knock-out in primary neuron provided protec-
tion from ER stress-induced JNK activation and cell death triggered 
by polyQ fragments78.
As the mutation in HTT can perturb the function of interacting 
proteins by aberrant binding, we checked for each of the 40 pro-
teins whether they have been reported to physically associate with 
HTT. Using molecular interaction data collected in HDNetDB, we 
detected that six of the 40 proteins interact with HTT i.e. ADD1, 
HSP90B1, IKBKB, RPS3A, IKBKG and LMNB1 (Supplementary 
data file 7). A visualisation of the UPR interactome with apoptosis-
related proteins and HTT interactors highlighted can be found in 
Figure 6.
Literature review showed that the two proteins kinases IKBKB and 
IKBKG, the laminin LMNB1 and the ribosomal protein RPS3A 
have been previously linked to neurodegenerative diseases. IKBKB 
and IKBKG are subunits of IkB kinase (IKK). They activate mem-
bers of the NF-κB transcription factor family by phosphorylation 
of their inhibitor (IkB)79 leading to ubiquitination and destruction 
of IkB, thereby allowing activation of the NF-κB complex. NF-κB 
maintains the balance between cell survival and apoptosis80. 
Although unrelated to ER stress, it has been shown that inhibition 
of IKBKB decreases HTT proteolysis in a cell model, and thus 
might lower the load of toxic HTT fragments in HD81. Recently, 
it has been reported that ubiquitination of IKBKG by Parkin, an 
ubiquitin ligase associated with Parkinson’s disease regulates the 
anti-apoptotic pathway that is key to maintaining mitochondrial 
integrity82.
Lamin B1 protein, LMNB1 is thought to be involved in nuclear 
stability and chromatin structure. Experiments in Caenorhabditis 
elegans overexpressing aggregation-prone peptides identified lam-
inins as modulators of protein toxicity at neuromuscular junctions83. 
Further, in leukodystrophy mouse models, lamin B1 acts as an 
Table 3. Differentially regulated UPR genes that interact with HTT and were 
classified as potential HD therapeutic targets (HDTT). + indicates the presence 
of ER stress-associated sequence motifs (UPRE, ERSE-I, ERSE-II) in the promoter 
regions (+1000 to -500 bp). Interaction type indicates whether the protein was 
shown to have a direct or indirect physical interaction. The Spearman correlation 
coefficient and the corresponding estimated fdr describe the correlation of gene 
expression with the length of polyglutamine tract in HD mice.
Gene UPRE ERSE-I ERSE-II Interaction type
CAG 
correlation 
coefficient
fdr cor.
RAB5A + + Indirect 0.48 0.0038
HMGB1 + + Indirect 0.39 0.026
CTNNB1 + Direct 0.82 0
DNM1 + + Direct 0.55 0.00050
TCP1 + + Indirect 0.62 0.00014
TUBB + + Indirect 0.60 0.00025
TSG101 + + Indirect 0.73 0
DNAJB1 + + Indirect -0.22 1
CCT2 Indirect 0.79 0
EEF2 Indirect 0.81 0
DYNC1H1 Indirect 0.57 0.00038
HSPA5 Indirect 0.07 0.81
SLC12A5 Indirect -0.06 1
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Figure  6.  Network  representation  of  UPR-apoptosis  connection.  The network displays UPR proteins and their interactions. Nodes 
indicate proteins and lines represent molecular interactions between them as derived from UniHI and HDNetDB. UPR proteins which are also 
associated with apoptosis are highlighted in red, while UPR proteins that are both associated with apoptosis and identified as HTT interactors 
are in green.
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important regulator of myelin formation and maintenance84, 
while in humans lamin B1 gene duplications85 and large dele-
tions upstream of promoter regions can cause autosomal-dominant 
leukodystrophy86. More importantly, a recent study reports increased 
levels of lamin B1 in both human HD patients and the R6/1 mouse 
model of HD87. Due to the involvement of lamin B1 in several cel-
lular alterations such as chromatin organisation, gene transcription 
and proteotoxicity, alterations in lamin B1 expression might have 
important implications in HD pathophysiology.
Finally, it has been demonstrated that apoptosis is induced by 
inhibiting the expression of ribosomal protein S3A (RPS3A)88. It 
also has been observed that SNP variants in RPS3A homologues 
are associated with pathogenesis of Alzheimer’s disease89. Apart 
from its function as a ribosomal protein, RPS3A might also act as 
a chaperone. Co-expression of mouse RPS3A suppressed the toxic-
ity induced by α-synuclein (which is a major components of Lewy 
bodies observed in Parkinson’s disease) in a yeast model system90.
As the literature review indicated, the intersection of the UPR inter-
actome with apoptosis-related genes and HTT interactors can point 
out proteins with potential relevance for neurodegeneration. Thus, 
the generated gene lists provided in the Supplementary data file 6 
and Supplementary data file 7 might give interested researchers a 
valuable basis for more detailed inspections.
Raw data for Kalathur et al., 2015 ‘The unfolded protein response 
and  its  potential  role  in  Huntington’s  disease  elucidated  by  a 
systems biology approach’
9 Data Files 
http://dx.doi.org/10.6084/m9.figshare.3080608
Conclusions
Various studies have indicated a role of the UPR in HD. However, 
its relevance for therapeutic interventions remains to be established. 
With the presented work, we aimed to delineate the connection 
between UPR and HD by examining available HD-relevant gene 
expression and molecular interaction data. We found indications 
for differential regulation of UPR genes in a number of expres-
sion studies. Notably, the observed differential regulation is not 
conserved across all evaluated studies reflecting the well-known 
heterogeneity of current HD models. This needs to be taken into 
account for future studies of the UPR in the context of HD. The 
results of our analysis (displayed in Figure 2) may therefore serve 
as guidance for the choice of model systems. Despite the observed 
heterogeneity, the comparison nevertheless indicated a number of 
genes that tend to be commonly regulated in different expression 
studies. This finding enabled us to define core sets of UPR genes 
that were commonly up- or downregulated in different studies. This 
derivation was supported by the detection of a significant overrep-
resentation of UPR-associated stress response elements (UPRE and 
ERSE) in the promoter regions of the upregulated genes. Moreover, 
we observed that expression of UPR genes in the striatum tend to 
correlate with the length of the HTT polyglutamine tract in mice. 
This is a remarkable observation, since human patients with longer 
polyglutamine tracts frequently display earlier age of disease onset 
and death. The observed strong correlation suggests that the UPR 
might contribute to dynamics of HD, and thus might present a prime 
target for inventions aiming to delay the appearance of symptoms 
and to decelerate disease progression.
Functional enrichment analysis on differentially expressed UPR 
genes pointed to a broad range of mechanisms involved. Additional 
pathway analyses indicated the activation of inflammatory proc-
esses and a potential connection to diabetes. Including complemen-
tary data sets, we identified UPR genes that have been indicated to 
influence HD pathogenesis. Finally, we derived sets of genes that 
connect UPR with apoptosis and might be directly influenced by 
mHTT.
In summary, through our work we present the first comprehensive 
analysis of UPR activation in HD and elucidate potential links to 
pathogenetic mechanisms within a systems biology framework. 
While our work cannot provide definite proofs for the identified 
relations due to its purely computational nature, it can neverthe-
less constitute a broad basis for experimental follow-up investiga-
tions. To assist such endeavours, extensive Supplementary material 
has been provided together with this article with the aim of helping 
independent researchers to select genes of interest. We have devel-
oped also a publicly accessible web-portal (http://uprhd.sysbiolab.eu) 
for the retrieval and visualisation of changes in UPR-associated 
gene expression across the evaluated transcriptomics studies. In 
conclusion, we hope that our work can contribute to a better under-
standing of the UPR in HD and eventually to the identification of 
novel therapeutic targets to cure HD.
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Supplementary information
Supplementary Figure 1. Comparison of UPR gene  lists. Venn 
diagram comparing the three different UPR genes lists generated.
Supplementary Figure 2. Common downregulated UPR genes. 
Comparison of several HD expression data sets to identify UPR 
genes that are downregulated in different HD models.
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Supplementary  Figure  3.  Comparison  of  UPRE  and  ERSE 
elements  in  the  promoter  region  of  UPR  genes  that  are 
upregulated in HD.
Supplementary  Figure  4.  UPR-HD  connectors.  Venn diagram 
showing common genes between 3 data sets, high stringency 
UPR-HDdiff: UPR genes that are differentially regulated in HD i.e. 
either upregulated in human HD iPSC and 6 murine HD models 
or downregulated in 5 murine HD models; HDTT: HD therapeutic 
targets as described by Kalathur RK et al.41 and originated by the 
HDCrossRoads database; and HTT-int: HTT interactors derived from 
the HDNetDB.
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Supplementary Figure 5. UPR-HD connectors  for  low stringency UPR-HDdiff. Venn diagram showing common genes between 3 data 
sets, low stringency UPR-HDdiff: UPR genes that are differentially regulated in HD i.e. either upregulated in human HD iPSC and at least 4 
of 6 murine HD models or downregulated in 4 murine HD models; HDTT: HD therapeutic targets as described by Kalathur RK et al.41 and 
originated by the HDCrossRoads database; and HTT-D-int: direct HTT interactors derived from the HDNetDB.
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Author Response 17 Feb 2016
, Centre for Biomedical Research, University of Algarve, PortugalRavi Kiran Reddy Kalathur
We thank the reviewer for the positive comments and specific suggestions that helped us to further
improve our manuscript. In the revised version, we have included the additional analysis suggest
by the reviewer.
We distinguish now between direct and indirect interactions of HTT based on their
annotation in HDNetDB. An additional supplementary table (Supplementary dataset 8)
presents now the classification of HTT interactions. This information was also used for the
interpretation of our results. For instance, 2 of the 13 proteins constituting a putative link
between HD and UPR, were direct interactors. We did not want to exclude a priori all
indirect HTT interactors, since those might be part of larger protein complexes with HTT and
thus potentially important for the HTT’s molecular functions.
 
Additional lists of genes with evolutionary conserved expression were generated for less
stringent filters (i.e. requiring the inclusion in the enrichment cores of at least 5 or 4
comparisons for up- or downregulated genes, respectively). In general, promotor and
enrichment analyses of the extended gene lists agree well with those for the more stringent
genes lists. The results are presented in supplementary tables and figures, and briefly
discussed in the main manuscript. For the connection to HD, lowering the requirement led to
detection of 53 candidates, of which 15 were direct HTT interactors (Supplementary figure
5). This enlarged set is presented in Supplementary dataset 9 for the interested reader.
 No competing interests were disclosed.Competing Interests:
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 Scott Zeitlin
Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA, USA
In HD and other neurodegenerative disorders involving the accumulation of misfolded protein, ER stress
and the activation of UPR have been implicated in pathogenesis, although the extent to which it
contributes to neuronal cell death is still unclear. In this paper, the authors employ a bioinformatic
approach to show that the unfolded protein response (UPR) is activated in a variety of human and animal
Huntington’s disease (HD) models. It is noteworthy that the authors also demonstrate that the
upregulation of the UPR genes is most likely a direct response to UPR activation by analyzing the
promoter regions of these genes for the binding sites of the UPR transcriptional activators ATF6 and
XBP1. Moreover, the authors also identified sets of genes that provide a potential link between both UPR
and HD and between UPR and apoptosis. Pathway enrichment analysis was also used to identify
functional pathways activated by the common set of upregulated UPR genes. In addition to the expected
pathways associated with UPR (e.g. PERK-regulated gene expression and ATF-activated genes), the
authors also identified components of the immune system, neurotrophin signaling, and diabetes.
Interestingly, there is evidence in the HD literature that all three of these latter pathways are affected in
HD.
This work is a good example of the power of using a systems biology approach to provide a fairly
comprehensive analysis of UPR activation in HD. The authors are appropriately cautious in emphasizing
that their results do not prove that the pathways and relationships between pathways that they have
identified all contribute to HD pathogenesis. However, their results provide an excellent guide for further
experimental studies, and the authors’ development of a publicly accessible web site for the retrieval and
visualization of their UPR-associated gene expression data in HD will be an important tool for the field that
will facilitate these future studies.
 
Minor comments:
In the introduction, the authors mention that although HTT is not located in the ER, there are there
are several potential mechanisms by which mutant HTT could induce ER stress (impairment of
ERAD, dysfunctional vesicular trafficking, and altered ER calcium homeostasis). Atwal et al., 
 and  have shown that there is a more direct link between HTT and(2007) Atwal and Truant (2008)
ER stress.  In their work, they show that the N17 domain of HTT is a stress-sensitive ER
association domain, and that the expanded polyQ stretch in mutant HTT perturbs the release of
mutant HTT from ER and its translocation of HTT into and out of the nucleus in response to cell
stress events.
 
p.7, 1  paragraph: “…UPR has been also associated with the suppression or degradation of a
substantial number of genes…. Do the authors mean: …UPR has been also associated with the
suppression or degradation of a substantial number of genes or gene products?
 
To account for the differences in differential UPR gene expression changes that were observed
among the different HD mouse models, the authors suggest that differences in the  transgenesHTT
and their expression levels among the models could be responsible. In addition, the different
genetic backgrounds of the models can contribute to the variability. In future studies aimed at
st
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genetic backgrounds of the models can contribute to the variability. In future studies aimed at
studying the role of the length of mutant HTT’s expanded polyQ stretch in UPR activation, the
authors may also want to consider evaluating CHDI’s publicly available transcriptome data
obtained from the cortex and striatum of 6-month old knock-in HD mouse models expressing
wild-type or mutant  alleles with different CAG repeat lengths.Htt
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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, Centre for Biomedical Research, University of Algarve, PortugalRavi Kiran Reddy Kalathur
We would like to thank the reviewer for the encouraging evaluating of our systems biology
approach and his suggestions for further improvement of the study and its presentation. In
response to the comments, following changes to the manuscript were made:
In the Introduction, we pointed out the finding of a stress-sensitive association of HTT with
the ER membrane, which suggests a potential direct role of HTT in ER stress. The relevant
references are now included.
 
We clarified the meaning of the sentence. It states now: “As the UPR has also been
associated with suppression of gene transcription and the enhanced degradation of
numerous transcripts, ...”
 
We would like to thank reviewer for pointing out this data set. We analysed the correlation of
expression changes with the length of polyglutamine tract. Notably, UPR genes were found
to be strongly overrepresented among genes whose expression in the striatum significantly
correlate with the length of polyglutamine tract. The correlation and the corresponding
significance are also shown for the potential UPR-HD connectors in table 3 and
Supplementary dataset 9. The results suggest length of the polyglutamine tract (which is
reversely correlated with age of disease onset in human patients) plays a critical role in the
activation of UPR. We aim to include these expression changes also in our newly developed
web-portal UPRHD at .http://uprhd.sysbiolab.eu
 No competing interests were disclosed.Competing Interests:
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